Pancreatic Cancer Research

ResearcherWenzhou Medical UniversityActive in the last 2 years

Shengjie Dai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-0276-3549; OpenAlex author ID A5020392344. Sources: OpenAlex.

Their work

Papers
10 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
23
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 2 papers · 2022: none · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. The Role of Mental and Physical Stress in the Occurrence and Development of Pancreatic Cancer. Co-author DOI 10.1002/smi.70235↗
  2. Metal-related cell death and its application in pancreatic cancer. Last author DOI 10.1017/erm.2025.10022↗
  3. Screening and Identifying m6A Regulators as an Independent Prognostic Biomarker in Pancreatic Cancer Based on The Cancer Genome Atlas Database. Co-author DOI 10.1155/2021/5573628↗
  4. Study of the Mechanism by Which Curcumin Cooperates with Sestrin2 to Inhibit the Growth of Pancreatic Cancer. Last author DOI 10.1155/2021/7362233↗
  5. Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. Co-author DOI 10.3389/fimmu.2020.00277↗
  6. Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26. Co-author DOI 10.3389/fimmu.2019.02819↗
  7. HNRNPA2B1 regulates the epithelial-mesenchymal transition in pancreatic cancer cells through the ERK/snail signalling pathway. Co-author DOI 10.1186/s12935-016-0368-4↗
  8. Erratum: Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells [Corri… Co-author DOI 10.2147/ott.s140829↗
  9. Isoorientin induces apoptosis, decreases invasiveness, and downregulates VEGF secretion by activating AMPK signaling in pancreatic cancer cells. Co-author DOI 10.2147/ott.s122653↗
  10. Luteolin decreases invasiveness, deactivates STAT3 signaling, and reverses interleukin-6 induced epithelial-mesenchymal transition and matrix metalloproteinase… First author DOI 10.2147/ott.s91511↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Tiantong Liu · 2 shared papers, 2025–2026 · strength 0.53
  2. Hongwei Sun · 2 shared papers, 2021–2026 · strength 0.43
  3. Hongwei Sun · 2 shared papers, 2020–2025 · strength 0.35
  4. Qinyu Lin · 1 shared paper, 2026 · strength 0.29
  5. Mengtao Zhou · 4 shared papers, 2015–2019 · strength 0.28
  6. Dinglai Yu · 3 shared papers, 2016–2021 · strength 0.27
  7. Chaohao Huang · 3 shared papers, 2016–2021 · strength 0.27
  8. Xince Huang · 4 shared papers, 2015–2017 · strength 0.26
  9. Chengchao Wang · 1 shared paper, 2025 · strength 0.24
  10. Hongwei Sun · 2 shared papers, 2019–2021 · strength 0.23
  11. Bicheng Chen · 3 shared papers, 2016–2017 · strength 0.20
  12. Keqing Shi · 2 shared papers, 2019–2020 · strength 0.20
  13. Mengtao Zhou · 2 shared papers, 2017–2020 · strength 0.18
  14. Fubiao Ni · 1 shared paper, 2021 · strength 0.14
  15. Ding Li · 1 shared paper, 2021 · strength 0.14
  16. Haotian Fu · 1 shared paper, 2021 · strength 0.14
  17. Yunfeng Shan · 1 shared paper, 2021 · strength 0.14
  18. Tingting Ye · 2 shared papers, 2016–2017 · strength 0.14
  19. Bi Lin · 1 shared paper, 2021 · strength 0.13
  20. Yukai Xiang · 1 shared paper, 2021 · strength 0.13
  21. Jie Zhang · 1 shared paper, 2017 · strength 0.07
  22. Bicheng Chen · 1 shared paper, 2015 · strength 0.06
  23. Yuwu Xiao · 1 shared paper, 2015 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.